drugset

drugset / Trial / NCT01985165

A Phase 4 Study of Imrecoxib in Treatment of Knee Osteoarthritis

NCT01985165 ↗

Phase 4 Unknown 2400 enrolled Jiangsu HengRui Medicine Co., Ltd.

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Imrecoxib in the treatment of patients with knee osteoarthritis.

Timeline

Start: 2013-05
Primary completion: 2013-11
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Imrecoxib	Small molecule	0.1 g	Oral

Indications